NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
0.6119
Dollar change
-0.0009
Percentage change
-0.15
%
Index- P/E- EPS (ttm)-1.16 Insider Own17.51% Shs Outstand162.66M Perf Week-11.51%
Market Cap99.54M Forward P/E- EPS next Y-0.71 Insider Trans250.67% Shs Float134.18M Perf Month24.88%
Enterprise Value24.29M PEG- EPS next Q-0.18 Inst Own27.56% Short Float8.86% Perf Quarter8.13%
Income-105.77M P/S- EPS this Y40.19% Inst Trans62.35% Short Ratio4.88 Perf Half Y-57.80%
Sales0.00M P/B0.83 EPS next Y9.87% ROA-64.32% Short Interest11.89M Perf YTD-57.21%
Book/sh0.73 P/C1.13 EPS next 5Y- ROE-76.21% 52W High4.06 -84.93% Perf Year-81.84%
Cash/sh0.54 P/FCF- EPS past 3/5Y9.39% -15.48% ROIC-81.66% 52W Low0.36 69.97% Perf 3Y-88.26%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility7.48% 9.97% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM31.02% Oper. Margin- ATR (14)0.05 Perf 10Y-
Dividend Ex-Date- Quick Ratio6.68 Sales Y/Y TTM- Profit Margin- RSI (14)53.98 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio6.68 EPS Q/Q38.57% SMA20-1.13% Beta3.00 Target Price10.14
Payout- Debt/Eq0.11 Sales Q/Q- SMA5017.00% Rel Volume0.32 Prev Close0.61
Employees97 LT Debt/Eq0.08 EarningsMay 07 AMC SMA200-52.61% Avg Volume2.43M Price0.61
IPOJul 30, 2021 Option/ShortYes / Yes EPS/Sales Surpr.-26.32% - Trades Volume779,192 Change-0.15%
Date Action Analyst Rating Change Price Target Change
Jun-10-24Initiated William Blair Outperform
Nov-30-23Initiated Leerink Partners Outperform $7
Jun-15-22Initiated H.C. Wainwright Buy $25
May-15-25 09:00PM
May-13-25 08:30AM
May-07-25 04:05PM
Apr-24-25 02:07PM
Apr-01-25 12:26PM
10:00AM Loading…
Mar-31-25 10:00AM
Mar-28-25 10:43AM
Mar-25-25 11:27AM
09:18AM
08:45AM
Mar-24-25 08:30AM
Mar-19-25 08:30AM
Mar-14-25 12:15PM
Mar-10-25 04:05PM
Mar-03-25 11:19PM
04:10PM Loading…
04:10PM
08:00AM
Feb-03-25 08:30AM
Jan-13-25 09:16AM
Dec-17-24 07:00AM
Dec-16-24 04:30PM
Nov-25-24 08:30AM
Nov-19-24 08:00AM
Nov-06-24 04:05PM
Nov-03-24 06:11AM
Oct-17-24 04:30PM
Sep-03-24 08:30AM
Aug-08-24 04:05PM
Jun-27-24 05:00PM
Jun-18-24 04:30PM
12:21PM Loading…
May-16-24 12:21PM
May-15-24 07:00AM
May-14-24 10:54PM
04:05PM
May-12-24 03:26PM
May-02-24 05:00PM
Mar-26-24 07:19AM
Mar-20-24 05:32AM
Mar-18-24 10:53PM
04:05PM
08:30AM
Feb-29-24 03:02AM
Feb-27-24 04:30PM
Feb-26-24 09:55AM
08:30AM
Feb-09-24 09:55AM
Feb-08-24 08:00AM
Jan-26-24 12:00PM
Jan-03-24 08:30AM
Nov-21-23 04:30PM
Nov-08-23 04:05PM
Oct-26-23 08:30AM
Oct-09-23 08:30AM
Oct-05-23 08:30AM
Oct-02-23 05:30PM
Sep-21-23 04:05PM
Aug-31-23 04:05PM
Aug-09-23 04:05PM
Aug-02-23 04:05PM
May-30-23 09:06AM
May-15-23 09:55AM
May-11-23 08:50AM
May-10-23 04:19PM
May-03-23 08:00AM
07:09AM
May-02-23 07:50AM
Apr-25-23 06:35AM
Apr-23-23 04:02PM
Apr-21-23 04:05PM
Apr-20-23 02:46PM
Apr-19-23 11:36AM
Mar-08-23 04:01PM
Feb-07-23 05:17PM
Jan-26-23 12:00PM
Jan-09-23 07:00AM
Dec-21-22 06:12AM
Dec-07-22 04:30PM
Dec-02-22 06:36PM
Nov-28-22 08:30AM
Nov-24-22 05:54AM
Nov-23-22 09:00AM
Nov-21-22 05:45PM
Nov-17-22 12:39AM
Nov-16-22 04:01PM
Nov-10-22 04:05PM
Nov-04-22 08:00AM
Oct-14-22 06:12AM
Oct-04-22 08:30AM
Sep-29-22 08:00AM
07:45AM
Sep-26-22 09:21AM
Sep-15-22 09:39AM
Sep-06-22 04:05PM
08:00AM
Aug-16-22 09:55AM
Aug-10-22 04:01PM
Jul-06-22 02:00PM
Jun-16-22 08:00AM
May-20-22 08:30AM
May-11-22 04:09PM
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Higa TomohiroSVP, FinanceMay 16 '25Sale0.441,39061598,300May 16 07:07 PM
Tingley WhittemoreChief Medical OfficerMay 16 '25Sale0.442,9371,300171,856May 16 07:07 PM
Ali FarazChief Executive OfficerMay 16 '25Sale0.443,1891,412317,325May 16 07:07 PM
Higa TomohiroSVP, FinanceMar 10 '25Sale0.542,4821,33699,690Mar 10 09:44 PM
Tingley WhittemoreChief Medical OfficerMar 10 '25Sale0.547,3983,983174,793Mar 10 09:43 PM
Ali FarazChief Executive OfficerMar 10 '25Sale0.549,7415,245320,514Mar 10 09:42 PM
Whittemore TingleyOfficerMar 10 '25Proposed Sale0.547,3983,983Mar 10 09:41 PM
Faraz AliOfficerMar 10 '25Proposed Sale0.549,7415,245Mar 10 09:40 PM
COLUMN GROUP III GP, LP10% OwnerMar 05 '25Buy0.7035,714,28424,999,99949,313,559Mar 07 07:14 PM
GOEDDEL DAVID VDirectorMar 05 '25Buy0.7035,714,28424,999,99949,313,559Mar 07 07:14 PM
Saito ChihiroSVP, Accounting and Fin. Ops.Nov 18 '24Sale2.122,2584,78760,983Nov 18 08:48 PM
Saito ChihiroSVP, Accounting and Fin. Ops.Aug 16 '24Sale2.892,3636,84063,241Aug 19 08:30 PM
Tingley WhittemoreChief Medical OfficerAug 16 '24Sale2.897,42821,500107,106Aug 16 08:26 PM
Ali FarazChief Executive OfficerAug 16 '24Sale2.899,74828,216188,331Aug 16 08:25 PM
Whittemore TingleyOfficerAug 16 '24Proposed Sale2.897,42821,467Aug 16 08:24 PM
Faraz AliOfficerAug 16 '24Proposed Sale2.899,74828,172Aug 16 08:23 PM